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Abstract  
 
Background: Mastitis reduces milk yield and alters milk composition. Antibiotics are widely used in the treatment of 
the disease. However, this widespread use of antibiotics causes both antibiotic residues in milks and antibiotic 
resistance developed in bacteria. Today’s researches are focused on discovering and using new antibiotics against 
bacteria. 
Objective: The aim of this work was to discover the antibacterial effects of Hypericum perforatum L. extracts against 
mastitis pathogens, and its other biological activities.  
Material and Methods: Kirby-Bauer assay was applied to the extracts. The other antibacterial activity was MIC for 
plant extracts. The non-enzymatic antioxidant activity was found using 2,2-diphenyl-1-picryl-hydrazyl-hydrate 
(DPPH).  
Results: The extract was showed maximum inhibition zone against two bacteria (Coagulase-negative Staphylococci- 
33 and 37; CNS 33 and 37), and the zone was 17 mm. A bacterium (CNS – 22) showed the lowest sensitivity to 812.5  
µg /mL concentration. In addition, the extract was tried against the stable DPPH  for antioxidant activity. As a result, 
the extract showed a strength antioxidant activity. Trolox equivalent is 0.83 mM.  
Conclusion: The extract of Hypericum perforatum have antibacterial, antioxidant and antimutagenic potentials.  
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Introduction 
Mastitis is a complex disease, which is defined as inflammation of parenchyma of mammary glands and is 
characterized by physical, chemical and usually bacteriological changes in milk and pathological changes in glandular 
tissues (Radostits et al., 2000). The widespread causative organisms of breast disease include: Staphylococcus, 
Streptococcus and coliform bacteria (McDonald, 1979). Coagulase-negative staphylococci (CNS) have been considered 
to be minor mastitis pathogens, especially in comparison with major pathogens such as Staphylococcus aureus. The 
main reason for this is that mastitis caused by CNS is very mild, and usually remains subclinical (Taponen et al., 2006). 
The significance of CNS, however, needs to be reconsidered as in many countries they have become the most common 
mastitis-causing agents (Pitkala et al., 2004; Tenhagen et al., 2006).  
Studies on medicinal plants are rapidly increasing because of the search for new active substances, and for the 
improvement in the production of plants or molecules for herbal pharmaceutical industries (Poutaraud et al., 2005). 
World Health Organization reported that, medicinal plants are the best source of drugs. However, these plants must be 
investigated  for their salient features, safety and effects (Nascimento et al., 2000). 
 Hypericum perforatum L. (St. John’s wort) is a well-known medicinal plant that has been in use for a decade 
(Gadzovska-Simic, 2012). This plant is a representative of the Hypericaceae family with confirmed therapeutic effects 
on burns, bruises, swelling, anxiety, mild to moderate depression (Luo, 2004), antidepressant, antiviral, wound healing, 
analgesic, hepatoprotective, antioxidant and antimicrobial activity (Jakovljevic, 2000;  Popovic, 2002; Radulovic, 
2007; Spiteller, 2008). Recently, the antiviral and antidepressant properties of Hypericum have become widely 
demonstrated (Luo, 2004). Extracts from H. perforatum are known to contain compounds from six major natural 
product groups: naphtodianthrones, acylphloroglucinols, flavonol glycosides, biflavones, proanthocyanidins, and 
phenylpropanes (Nahrstedt and Butterweck 1997). A lot of plants have been used due to their biological activities. 
Because, these plants synthesize sekonder substances. The biological activities of Hypericum perforatum flower 
extracts against mastitis bacteria have not been studied. Additionally, antioxidant activities of H. perforatum flower 
extracts is less studied comparing to its other biological impacts. In our work, the methanol extract of flower was 
investigated for antibacterial, non-enzymatic antioxidant and antimutagenic effects. 
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Material and Methods 
Plant Material 
 
Hypericum perforatum flowers were picked up from different locations of Selcuk, Izmir region, Turkey in 
2014. Taxonomical identification of plant was performed by Dr. Olcay Ceylan from the University of Mugla Sitki 
Kocman, Turkey and a specimen was stored in the herbarium. The identity of these specimen was applied by the Flora 
of Turkey (Davis, 1965).  
The flowers were cleaned thoroughly 2-3 times with flowing  and sterile distilled water. Green flower material 
was dried by air. These flowers pulverized in a disruptive mill. All of samples were stocked at room temperature. Then 
the flowers were stocked at 4°C until needed for assay. 
Plant Extraction 
The dried materials (30 g) were extracted with organic solvent (methanol) by the Soxhlet apparatus. These 
materials were evaporated. Then materials were stored in mat bottles. These vials were stored refrigerated until use 
(100 mg/mL). 
Microorganisms and Cultivation 
In this work, Hypericum perforatum flowers extracts were singly tried against mastitis bacteria. These 
pathogens provided from previous studies by Dr. Zafer Cantekin, Mustafa Kemal University, TURKEY (Project 
number: 1101 M 0103; Ethics council number: 2010 / 02- 30: 12). We have been used two S. aureus and five 
coagulase- negative staphylococci (CNS) in our study. These pathogens were grown at 37 °C for 24 hour. We were 
used Mueller - Hinton Broth (MHA) for cultivation of bacteria. All of bacteria were identified by traditional 
biochemical tests (Quinn, 1994).  
Antibacterial Activity Assay 
In this study, Kirby – Bauer assay was applied  for antibacterial activities. The bacteria were preserved on 
MHA plates at 37 °C (Bauer, 1966). Bacterial cultures adjusted to 0.5 Mc Farland. Incubations of bacteria were at 37 °C 
for 24 hour. The assessment of antibacterial activity was based on measurement of the diameter of the inhibition zones 
around the discs after 24 hour. We have used methanol and ampicillin (10μg) as control in our study.  All tests were 
performed in triplicate and the mean values were given. 
Minimum Inhibitory Concentration Assay (MIC) 
The MICs of plant extracts were measured by broth dilution assay. The MIC values were given as the lowest 
concentration of plant extracts. The broth dilution assay was done according to CLSI standards (CLSI, 2003; CLSI, 
2006). We have used final concentrations of the extract in our work. These concentrations were from 6500 µg/mL to 
406.25 µg/mL (6500; 3250; 1625, 812.5, and 406.25 µg/mL). 
Determination of non-Enzymatic Antioxidant Activity 
The non-enzymatic antioxidant activity was decided using DPPH free radical. The stable DPPH was used for 
determination of free radical-scavenging activity of the flower extract. Extract (0.1 mL) was added to methanol 
DPPH mixture (0.1 mM). This solution was incubated for 30 minutes and after, absorbance of solution  was measured 
spectrophotometrically. Blank was methanol. We have used methanol with DPPH solution as control (Brand-
Williams, 1995). Additionally trolox was used for reference. The free radical scavenging capacity expressed in 
percentage (%) was calculated from formula. 
Antimutagenic Activity Assay 
Antimutagenic activities of extracts were done by the Salmonella-microsome assay. In this study, Salmonella 
Typhimurium tester strains were used for antimutagenic activity tests. These bacteria were provided from previous 
studies by Dr. B.N. Ames (Maron and Ames, 1983). In our study, two tester strains were utilized to test the 
antimutagenicity of H. perforatum extract. These bacteria are Salmonella Typhimurium TA98 and TA100. The 
calculation percentage of antimutagenic activity was done according to Ong et al. (1986). Sodium azide was used as 
positive control. Methanol is negative control. Concurrently, a positive control (with mutagen but no extract was 
added) and a negative control (where no mutagen was added) were also set. The test sample was dissolved in methanol. 
But mutagen was dissolved in distilled water. In our study, non-toxic concentrations of the test sample used for 
investigating were 12500 and 25000 µg /plate. These concentrations were categorized as non-toxic because they 
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showed a well-developed lawn, almost similar size of colonies and no statistical difference in the number of 
spontaneous revertants in test and control plates.  
 
Results 
The antibacterial activities of flower extracts were tried against mastitis bacteria. Results of this study are 
given in Table 1. The results of inhibition zones  were recorded as  mm. The extracts suppressed the growth of bacteria. 
These inhibition zones formed against bacteria ranged between 13- 17 mm. Hypericum perforatum extracts have been 
quite effective against 2 bacteria. The highest inhibition zone was determined in CNS-33 and 37, and its zone was 17 
mm. Ampicillin (10μg) is  positive control. Ampicillin very strongly supressed the growth of S. aureus- 17 (Table 1).  
 
Table 1: Antibacterial activities of Hypericum perforatum flower extracts 
 
Bacteria Inhibition zone diameters (mm) Ampicillin 
S. aureus- 17 13 18 
S. aureus- 18 16 12 
CNS - 22 16 - 
CNS - 32 16 10 
CNS - 33 17 8 
CNS - 36 16 - 
CNS - 37 17 - 
CNS: Coagulase Negative Staphylococci 
Table 2 shows MICs of H. perforatum obtained by the broth dilution method. CNS-22 demonstrated the 
lowest susceptibility to methanol extract (812.5 µg /mL) (Table 2). 
 
Table 2: Minimum inhibitory concentrations of Hypericum perforatum flower extracts 
Bacteria                   Minimum inhibitory concentration  
                         (methanol;    µg/mL) 
S. aureus- 17 3250 
S. aureus- 18 1625 
CNS – 22 812.5 
CNS – 32 1625 
CNS – 33 1625 
CNS – 36 1625 
CNS – 37 1625 
CNS: Coagulase Negative Staphylococci 
DPPH radical scavenging capacity was used for antioxidant activities of the flower extracts. The antioxidant 
activities of flower extracts shown in Table 3. The extract showed 32 % inhibition at 100 mg/mL extract concentration. 
Trolox equivalent value was 0.83 mM/g DW (Table 3). 
 
 
Table 3: DPPH radical scavenging capacity of H. perforatum flower extract 
Flower extracts DPPH (%) Trolox equivalent 
(mM/gDW) 
Methanol 32 0.83 
DW: dry weight    
 
The antimutagenic capacities of H. perforatum flowers are given in Table 4 and 5. In this work, to determine 
the antimutagenic activity of H. perforatum, diagnostic mutagens were inoculated in the sample petri dishes, and two 
strains were used to measure this activity. H. perforatum flower extract (25000 µg /plate) calculated a strong positive 
inhibitory influence for S. Typhimurium TA98 (64.6%) and S. Typhimurium TA100 (49.7%) (Table 4).  
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Table 4: Antimutagenic activities of H. perforatum flower extracts (25000 µg /plate) 
Treatment   
Salmonella Typhimurium TA98 Salmonella Typhimurium TA100 
Number of 
revertants % Inhibition 
Number of 
revertants % Inhibition 
Control 42  84  
Negative control (methanol) 43  87  
Pozitive control (sodium azid) 113  161  
H. perforatum extract 40 % 64.6 81 % 49.7 
A moderate inhibitory impact (39%) for S. Typhimurium TA 100 was determined from H. perforatum flower 
extract (12500 µg /plate). Whereas H. perforatum flower extract (12500 µg /plate) showed strong inhibitive effect 
(58%) for S. Typhimurium TA98 (Table 5). 
 
Table 5: Antimutagenic activities of H. perforatum flower extracts (12500 µg /plate) 
Treatment   
Salmonella Typhimurium TA98 Salmonella Typhimurium TA100 
Number of 
revertants % Inhibition 
Number of 
revertants % Inhibition 
Control 42  84  
Negative control (methanol) 43  87  
Pozitive control (sodium azid) 113  161  
H. perforatum extract 47 % 58.4 98 % 39.1 
Discussion  
 
Plant oils and extracts have been used for a wide variety of purposes for many thousands of years (Jones, 
1996). Scientists proved that medicinal plants have rich sources of biologically active compounds. Many of these 
materials have been used as compounds to improve novel medicinal drugs (Palombo, 2011). This study confirms that 
H. perforatum flowers possess antibacterial, antioxidant and antimutagenic activities.  
In the present study, the methanol extracts were tried against mastitis pathogens. These results were compared 
with ampicillin. H. perforatum flowers demonstrated low impact against a bacterium (Table 1). Meral and Karabay 
(2002) reported parallel results. This report support the results of our study. In our work, the methanol extracts were 
found highly effective for six bacteria, except S. aureus- 17 (Table 1). Hypericum extract demonstrated bactericidal 
activity in vitro against a number of Gram positive and Gram negative bacteria, including Staphylococcus aureus, 
Proteus vulgaris, Escherichia coli and Pseudomonas aeruginosa (Barbagallo and Chisari, 1987). Keleş et al., (2001) 
found that extract of H. perforatum has a broad spectrum of inhibitory activity. Additionally the extract of H. 
perforatum showed an inhibitory effect of 16 and 14 mm against Staphylococcus aureus, Streptococcus agalactiae, 
respectively (Keleş et al., 2001). The report support the results obtained from our study. Rancic et al., (2005) declared 
that extract of H. perforatum has demonstrated inhibition against S. aureus and this  zone is  5 mm. Results of our study 
are better than Rancic's result (2005). It is not surprising that there are differences in the antibacterial effects of plant 
groups, due to phytochemical differences among species.  
The lowest sensitivity to methanol extracts determined on CNS-22 (Table 2). Dordevic et al., (2013) reported 
that minimum inhibitory concentration value (MIC) of H. annulatum and H. elegans essential oils against S. aureus 
was found as 3.13 mg/mL. In other study, essential oil isolated from the aerial parts of H. rumeliacum exhibited 
moderate activities against all the tested bacteria (S. aureus, S. epidermidis, E. coli, Enterobacter cloacae, Klebsiella 
pneumoniae, Pseudomonas aeruginosa), with a MIC of 3.80–17.20 mg/mL (Couladis et al., 2003). In our work, the 
lowest MIC value of flower extract was determined as 812.5 μg/mL. Our findings are better than MIC results of other 
scientists (Dordevic et al., 2013; Couladis et al., 2003). Aligiannis et al,. (2001) reported that plant materials were able 
to be classified based on MIC results. The methanol extracts of H. perforatum can be accepted as low inhibitor against 
mastitis bacteria. Saroglou et al., (2007) reported that MIC value of H. perforatum was 12.5 μg/mL for S. aureus. The 
reason for this may be the plant composition. Essential oils content and composition can be greatly affected by several 
parameters including seasonal variation (Guedes et al., 2004), phenological cycle (Schwob et al., 2004) and geographic 
distribution. 
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Cai et al., (2004) reported that free radical scavenging abilities of plants are responsible for their curative 
impact against some diseases. The antioxidant activity of H. perforatum is given in Table 3. The flower extract was 
inhibited free radical and inhibition was determined as 32 % at 100 mg/mL extract concentration. Trolox equivalent 
value was 0.83 mM/g DW. Wojdylo et al., (2007) reported that antioxidant capacity of H. perforatum was found as 
82.3 μM trolox/100 g dw. These results of Wojdylo et al., (2007) were not as good as our results.  Vardapetyan et al., 
(2014) reported that the highest radical scavenging capacity was found in ethanolic extract of H. perforatum leaves. 
Variations in essential oil composition of several species of the Hypericum genus were previously reported, depending 
on genetic factors (Petrakis et al., 2005), geographical distribution and environmental factors (Couladis et al., 2001; 
Smelcerovic et al., 2007), ontogeny (Schwob et al., 2004; Nogueira et al., 2001), and plant organ (Bertoli et al., 2003). 
In this work, H. perforatum flower extract (25000 µg /plate) demonstrated a strong positive inhibition for 
Salmonella Typhimurium TA98 (64.6%)  and S. Typhimurium TA100 (49.7%) (Table 4). Peron et al., (2013) showed 
that this plant had no mutagenic potential in subchronic gavage treatments (0.3, 3.0 and 30.0 mg/mL). Ndhlala et al., 
(2011) determined that H. aethiopicum was not mutagenic by the Ames test with Salmonella Typhimurium. The reports 
support the results obtained from this work. In present study, H. perforatum flower extract (12500 µg /plate) was given 
a positive inhibitory impact against S. Typhimurium TA98 (58%). In addition, this dose was showed moderate 
inhibitory effect  for S. Typhimurium TA100 (39%) (Table 5). An antimutagenic activity was demonstrated by 
Hypericum extract on DNA repair in Escherichia coli (Vukovic-Gacic and Simic, 1993). The report support our results 
obtained from study.  
 
Conclusion  
In conclusion, methanol extract of H. perforatum tested in the study was determined to have potential 
antibacterial activities against S. aureus and CNS pathogens isolated from subclinical cow mastitis. Our findings 
recommend that H. perforatum has important antibacterial activity. We believe that it could be very beneficial in the 
field of new antibacterial agents of plant origin. Furthermore, methanol extracts of the plant have less importance as 
antioxidant activities. Additionally, this plant was showed antimutagenic properties and which is high important. The 
study suggests that Hypericum perforatum, owing to its antimutagenic property, can be beneficial for prevention of 
cancer. Further research is required to determine the best antioxidant, antimutagenic and antibacterial agents. 
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